The link between serum insulin-like growth factor 1 (IGF-1) and postmenopau
sal osteoporosis remains controversial. In this study of healthy postmenopa
usal women, decreased serum concentrations of IGF-1 were strongly associate
d with an increased risk of osteoporotic fractures independently of bone-mi
neral density.